GLOBAL BIODEFENSE – Swissmedic, the Swiss regulatory authority for therapeutic products, has approved a second Swiss trial of an experimental Ebola vaccine. The trial will be led by the University Hospitals of Geneva (HUG). Pending positive safety data, larger scale trials will be taken to African countries as early as January 2015. Continue